Spyre Therapeutics Inc
(FRA:3920)
€
30.65
1.15 (3.9%)
Market Cap: 1.64 Bil
Enterprise Value: 1.50 Bil
PE Ratio: 0
PB Ratio: 8.15
GF Score: 51/100 We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey